You are here
Welcome and brief opening plenary
Professor Nicolas Mottet Université Jean Monnet, St. Etienne, introduces to the following sessions covering the best treatment strategies for individual patients with metastatic castration resistant prostate cancer and newly diagnosed advanced prostate cancer. Although clinical trials show positive results which improve survival of patients and help to optimize guidelines there is a big difference to real life patients. This is based on the selection criteria of these clinical trials excluding patients with cardiac, hepatic, renal or neurologic comorbidities thereby limiting the generalizability of trial results explains Professor Nicolas Mottet.